BioCentury
ARTICLE | Company News

Management tracks

March 25, 2015 1:32 AM UTC

The Innovative Medicines Initiative (IMI) named Marc de Garidel as chair of its governing board. Garidel succeeds Roch Doliveux, who retired last year. Garidel is chairman and CEO of Ipsen Group (Euronext:IPN; Pink:IPSEY).

Infectious disease company Aridis Pharmaceuticals LLC (San Jose, Calif.) hired Paul-Andre de Lame as CMO. He was co-founder and CMO of Cardiokine Inc. ...